Journals
Publish with us
Publishing partnerships
About us
Blog
Tuberculosis Research and Treatment
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Tuberculosis Research and Treatment
/
2023
/
Article
/
Tab 2
/
Research Article
Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization
Table 2
Genotypic drug resistance frequency among M. tuberculosis strains of lymphadenitis TB patients at ALERT and St. Peter TB Specialized Hospital, Addis Ababa, Ethiopia.
Variables
First-line genotypic DST
Percentage (%)
Resistant to any single drug.
(
)
Rifampicin
3
6%
Isoniazid
7
14%
Resistant to only a single drug.
(
)
Isoniazid only
4
8%
Resistant to both drugs.
(
)
Rifampicin + isoniazid
3
6%